Table 3a.
Detail of selected 5 ligand complex from 1 ns molecular dynamics simulation study on the basis of physiological interacting residues (A: LYS417, GLN409, ARG408, B: PHE374)
| Drug code | Drug name | Docking score | Interacting residues |
|---|---|---|---|
| LA (normal) | −7.540 | A: LYS417, GLN409, ARG408 B: PHE374 | |
| DB00650 | Leucovorin | −11.804 | A: LYS417, GLN409, ARG408 B: PHE374 |
| DB11362 | Selexipag | −11.463 | A: LYS417, GLN409, ARG408 B: PHE374 |
| DB00642 | Pemetrexed | −11.091 | A: LYS417, ARG408, GLN409 B: PHE374, phe377 |
| DB00310 | Chlorthalidone | −10.984 | A: ARG408, GLN409, LYS417, THR415 B: PHE377, PHE374 |
| DB06813 | Pralatrexate | −10.758 | A: LYS417, GLN409, ARG408 B: PHE392, PHE338, PHE377, PHE374 |
LA=Linoleic acid